Indication
Treatment of metastatic and early breast cancer and metastatic gastric cancer (MGC).
Loading your page…
Loading your page…
Breast Neoplasms;Stomach Neoplasms
Marketing Authorisation Holder: Sandoz GmbH
EMA Authorisation: 15/11/2023
INN: trastuzumab
AI Drug & Interaction Analysis
Free account required
Ask Osler about Herwenda: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.